)
Christophe Bonneville
CEO
Dillico
Christophe Bonneville leads the company's global strategy with a vision that champions the adoption of Pharma 4.0 solutions on the global pharma market. Previously, he was co-founder and CEO of Resolution Spectra, which was acquired by Merck Millipore in 2020 for its bioprocess monitoring solution. He has also held Business Unit Manager and Program Manager roles at various companies in the space industry. He holds a PhD in Physics, specifically in the field of Instrumental Optics, and is a graduate of Ecole Centrale de Marseille in France.
Sessions
-
22-Jun-2026Theater 3Dillico
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}